Rivatroy 15 Tablet
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Rivaroxaban (15mg)
Overview Rivatroy 15 Tablet
Thrombostop 15mg tablets function as an anticoagulant, preventing and treating blood clots to mitigate stroke and heart attack risks. This medication inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clotting, it also lowers post-surgical (knee or hip replacement) thromboembolic risk. It can be administered with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration requires physician consultation to avoid increased heart attack, stroke, or thrombosis risk. Lifestyle modifications such as smoking cessation, a balanced diet, regular exercise, and weight management further reduce clotting risks. Increased bleeding (e.g., nosebleeds, bruising) is a prevalent side effect; report any adverse reactions promptly. Contraindicated in individuals with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring is unnecessary.
Primary Ingredients of Rivatroy 15 Tablet
The provided text is "undefined," which cannot be rephrased while maintaining meaning and intent. There is no original text to rewrite.
Uses of Rivatroy 15 Tablet
Managing and averting blood clot formation.
Major Benefits of Rivatroy 15 Tablet:
Administer this medication precisely as your physician directs, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Rivatroy 15 Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Rivatroy 15 Tablet:
- Bleeding
How to use Rivatroy 15 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rivatroy 15 Tablet. The tablet should be swallowed whole; do not break, crush, or chew it. While it can be taken with or without food, consistency is key – take it at the same time each day.
How Rivatroy 15 Tablet works:
Xarelto 15 mg tablets represent a new class of oral blood thinners. Their mechanism involves inhibiting factor Xa, a key component in blood coagulation, thus reducing the likelihood of clot development.
SAFETY ADVICE
AlcoholCAUTION
Use of Rivatroy 15 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Rivatroy 15 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Rivatroy 15 Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Rivatroy 15 Tablet, which can induce dizziness or fainting. Side effects from Rivatroy 15 Tablet may impact your capacity to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Rivatroy 15 Tablet, as dose modification may be necessary. Consultation with a physician is advised. Rivatroy 15 Tablet is contraindicated in individuals with severely compromised kidney function.
LiverUNSAFE
Patients with liver conditions should not take Rivatroy 15 Tablet; its use is considered potentially hazardous. A physician's advice is necessary.
What if you forget to take Rivatroy 15 Tablet :
Should you forget to take a Rivatroy 15 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rivatroy 15 Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine-thiophene derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Xa Inhibitors for Oral Administration |


